Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ankri

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
Therapeutic Drug Monitoring|December 29, 2000
Prediction of fluindione maintenance dosage hampered by large intraindividual variabilityE Comets, F Pousset, F Mentré, et al.
Annales De Biologie Clinique|August 7, 2004
[Lupus-like circulating anticoagulant or antifactor? Preoperative difficult diagnosis]I Martin-Toutain, T Vu, Z Azgui, et al.
Acta Anaesthesiologica Scandinavica|April 1, 1994
Intraoperative measurement of activated partial thromboplastin time and prothrombin time with a new compact monitorC M Samama, R Quezada, B Riou, et al.
Annales Francaises D'Anesthesie Et De Reanimation|January 1, 1990
[Mechanisms and prediction of hemorrhagic complications during surgery of thoraco-abdominal aortic aneurysms]G Godet, C M Samama, A Ankri, et al.
Thrombosis Research|January 15, 1996
Evidence for a relationship between plasminogen activator inhibitor-1 and gamma glutamyl transferaseJ P Bastard, E Bruckert, D Porquet, et al.
Lupus|April 4, 2007
High prevalence of antibodies to platelet factor 4 heparin in patients with antiphospholipid antibodies in absence of heparin-induced thrombocytopeniaI Martin-Toutain, J C Piette, M C Diemert, et al.
European Heart Journal|December 1, 1992
Lack of platelet-activating factor release during reversible myocardial ischaemiaG Montalescot, J Maclouf, G Drobinski, et al.
Fundamental & Clinical Pharmacology|December 18, 2004
Beraprost sodium-fluindione combination in healthy subjects: pharmacokinetic and pharmacodynamic aspectsD Warot, I Berlin, G Aymard, et al.
Anesthesia and Analgesia|May 29, 2001
Hemostatic changes in patients receiving hydroxyethyl starch: the influence of ABO blood groupC Huraux, A Ankri A, D Eyraud, et al.
Annales Francaises D'Anesthesie Et De Reanimation|January 1, 1989
[Are hemorrhagic complications after surgery of thoracic-abdominal aneurysms predictable?]C M Samama, G Godet, A Ankri, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Therapeutic Drug Monitoring|December 29, 2000
Prediction of fluindione maintenance dosage hampered by large intraindividual variabilityE Comets, F Pousset, F Mentré, et al.
Annales De Biologie Clinique|August 7, 2004
[Lupus-like circulating anticoagulant or antifactor? Preoperative difficult diagnosis]I Martin-Toutain, T Vu, Z Azgui, et al.
Acta Anaesthesiologica Scandinavica|April 1, 1994
Intraoperative measurement of activated partial thromboplastin time and prothrombin time with a new compact monitorC M Samama, R Quezada, B Riou, et al.
Annales Francaises D'Anesthesie Et De Reanimation|January 1, 1990
[Mechanisms and prediction of hemorrhagic complications during surgery of thoraco-abdominal aortic aneurysms]G Godet, C M Samama, A Ankri, et al.
Thrombosis Research|January 15, 1996
Evidence for a relationship between plasminogen activator inhibitor-1 and gamma glutamyl transferaseJ P Bastard, E Bruckert, D Porquet, et al.
Lupus|April 4, 2007
High prevalence of antibodies to platelet factor 4 heparin in patients with antiphospholipid antibodies in absence of heparin-induced thrombocytopeniaI Martin-Toutain, J C Piette, M C Diemert, et al.
European Heart Journal|December 1, 1992
Lack of platelet-activating factor release during reversible myocardial ischaemiaG Montalescot, J Maclouf, G Drobinski, et al.
Fundamental & Clinical Pharmacology|December 18, 2004
Beraprost sodium-fluindione combination in healthy subjects: pharmacokinetic and pharmacodynamic aspectsD Warot, I Berlin, G Aymard, et al.
Anesthesia and Analgesia|May 29, 2001
Hemostatic changes in patients receiving hydroxyethyl starch: the influence of ABO blood groupC Huraux, A Ankri A, D Eyraud, et al.
Annales Francaises D'Anesthesie Et De Reanimation|January 1, 1989
[Are hemorrhagic complications after surgery of thoracic-abdominal aneurysms predictable?]C M Samama, G Godet, A Ankri, et al.
Pageof 6